Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M15,632Revenue $M13,782Net Margin (%)2.0Altman Z-Score2.1
Enterprise Value $M23,069EPS $1.2Operating Margin %8.5Piotroski F-Score6
P/E(ttm)61.6Beneish M-Score-2.7Pre-tax Margin (%)5.3Higher ROA y-yN
Price/Book3.210-y EBITDA Growth Rate %11.7Quick Ratio1.8Cash flow > EarningsY
Price/Sales1.25-y EBITDA Growth Rate %9.5Current Ratio1.9Lower Leverage y-yN
Price/Free Cash Flow19.2y-y EBITDA Growth Rate %-24.6ROA % (ttm)1.5Higher Current Ratio y-yY
Dividend Yield %--PEG6.3ROE % (ttm)5.4Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M207ROIC % (ttm)5.4Gross Margin Increase y-yN

Gurus Latest Trades with DVA

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
DVAArnold Van Den Berg 2016-03-31 Add0.76%$62.24 - $73.38
($67.47)
$ 75.8312%Add 22.67%328,908
DVASteve Mandel 2015-12-31 Sold Out -2.41%$67.79 - $78.16
($73.23)
$ 75.834%Sold Out0
DVAArnold Van Den Berg 2015-12-31 Reduce-0.22%$67.79 - $78.16
($73.27)
$ 75.833%Reduce -6.22%268,133
DVAJoel Greenblatt 2015-12-31 Add0.19%$67.79 - $78.16
($73.23)
$ 75.834%Add 525.25%302,502
DVAMario Gabelli 2015-12-31 Reduce$67.79 - $78.16
($73.23)
$ 75.834%Reduce -4.31%39,963
DVAArnold Van Den Berg 2015-09-30 Add1.63%$70.93 - $81.14
($77.54)
$ 75.83-2%Add 85.75%285,918
DVASteve Mandel 2015-09-30 Add0.75%$70.93 - $81.14
($77.54)
$ 75.83-2%Add 45.15%7,918,998
DVAJoel Greenblatt 2015-09-30 Buy 0.03%$70.93 - $81.14
($77.54)
$ 75.83-2%New holding48,381
DVAArnold Van Den Berg 2015-06-30 Reduce-0.11%$79.47 - $84.23
($82.11)
$ 75.83-8%Reduce -5.86%153,928
DVAMario Gabelli 2015-06-30 Add$79.47 - $84.23
($82.11)
$ 75.83-8%Add 5.29%41,763
DVAArnold Van Den Berg 2015-03-31 Buy 1.87%$72.78 - $82.84
($76.74)
$ 75.83-1%New holding163,503
DVASteve Mandel 2015-03-31 Add0.47%$72.78 - $82.84
($76.74)
$ 75.83-1%Add 38.47%5,455,774
DVAJoel Greenblatt 2015-03-31 Sold Out -0.22%$72.78 - $82.84
($76.74)
$ 75.83-1%Sold Out0
DVAMario Gabelli 2015-03-31 Reduce$72.78 - $82.84
($76.74)
$ 75.83-1%Reduce -7.25%39,663
DVASteve Mandel 2014-12-31 Buy 1.3%$72.03 - $78.07
($75.35)
$ 75.831%New holding3,940,169
DVAJoel Greenblatt 2014-12-31 Add0.16%$72.03 - $78.07
($75.35)
$ 75.831%Add 240.25%352,562
DVAMario Gabelli 2014-12-31 Reduce-0.03%$72.03 - $78.03
($75.28)
$ 75.831%Reduce -63.03%42,763
DVASteve Mandel 2014-06-30 Sold Out -1.1%$67.12 - $72.95
($69.49)
$ 75.839%Sold Out0
DVAJoel Greenblatt 2014-06-30 Reduce-0.11%$67.12 - $72.95
($69.49)
$ 75.839%Reduce -49.01%110,765
DVAMario Gabelli 2014-06-30 Add0.03%$67.12 - $72.95
($69.49)
$ 75.839%Add 330.08%114,328
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

DVA is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


DVA: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Rodriguez JavierCEO-Kidney Care 2016-04-11Sell89,912$73.513.16view
Kogod DennisPres, HCP & CEO, DVA Int. 2016-03-21Sell13,455$72.125.14view
Arway Pamela MDirector 2016-02-29Sell9,026$6614.89view
ZUMWALT LEANNE MGrp VP, Purch & Public Affairs 2016-02-23Sell14,587$64.2518.02view
Kogod DennisPres, HCP & CEO, DVA Int. 2016-02-16Sell33,290$61.9922.33view
Mildenberger LauraChief People Officer 2015-12-17Sell1,440$68.1411.29view
THIRY KENT JChairman and CEO 2015-11-09Sell300,000$75.610.29view
Rivera Kim MChief Legal Officer 2015-09-22Sell40,037$75.480.46view
DAVIDSON CAROL ANTHONYDirector 2015-08-17Sell4,038$79.93-5.13view
JIGANTI JEANINE MARIEChief Compliance Officer 2015-08-10Sell1,311$81.32-6.75view

Press Releases about DVA :

Quarterly/Annual Reports about DVA:

News about DVA:

Articles On GuruFocus.com
Arnold Van Den Berg's Largest Buys in 1st Quarter Apr 21 2016 
Weekly CEO Sells Highlights Apr 18 2016 
7 High Quality Guru Stocks Apr 11 2016 
Steve Mandel Sells Health Care Stakes Mar 11 2016 
Undervalued, Predictable Companies Include Monsanto and Western Union Mar 10 2016 
Alan Fournier Makes Modest Reductions in Middleby and Priceline Jan 12 2016 
Allergan Among Health Care Holdings in Alan Fournier's Portfolio Dec 15 2015 
Starting With GAAP Jun 11 2015 
Berkshire Hathaway: Business Value Exceeds Market Value May 26 2015 
Manning & Napier's Top 5 Stock Selections of Q1 Apr 21 2015 

More From Other Websites
DaVita HealthCare (DVA) Q1 Earnings Beat as Revenues Rise May 05 2016
Edited Transcript of DVA earnings conference call or presentation 4-May-16 9:00pm GMT May 05 2016
DaVita HealthCare Partners Inc Earnings Call scheduled for 5:00 pm ET today May 04 2016
DaVita HealthCare tops Street 1Q forecasts May 04 2016
DaVita HealthCare tops Street 1Q forecasts May 04 2016
DAVITA HEALTHCARE PARTNERS INC. Files SEC form 8-K, Results of Operations and Financial Condition,... May 04 2016
4:02 pm DaVita creates a l/t JV w/ Khazanah Nasional Berhad, the strategic investment fund of the... May 04 2016
DaVita HealthCare Partners Inc. 1st Quarter 2016 Results May 04 2016
Q1 2016 DaVita HealthCare Partners Inc Earnings Release - After Market Close May 04 2016
Watch for Healthcare Stocks in Q1 Earnings: DVA, HCA, HUM May 02 2016
DaVita (DVA) Likely to Top Q1 Earnings: Stock to Gain? May 02 2016
DaVita HealthCare Partners Inc. Schedules 2016 Capital Markets Day Apr 26 2016
DaVita HealthCare Partners Inc. Schedules 1st Quarter 2016 Investor Conference Call Apr 26 2016
(TOFR) Playing Stock Splits with the TOFR ETF Apr 22 2016
Weekly CEO Sells Highlights Apr 18 2016
DaVita to Acquire Mountain View, Expand Footprint in Colorado Apr 11 2016
Mountain View Medical Group to Join DaVita HealthCare Partners Apr 08 2016
DaVita Kidney Care Releases Free Kidney-Friendly Cookbook Apr 07 2016
DAVITA HEALTHCARE PARTNERS INC. Files SEC form 8-K, Regulation FD Disclosure Apr 06 2016
UBS Says Buy Berkshire Hathaway: What You Need To Know Mar 29 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)